Your browser is no longer supported. Please, upgrade your browser.
Settings
CRL Charles River Laboratories International, Inc. daily Stock Chart
CRL [NYSE]
Charles River Laboratories International, Inc.
Index- P/E28.15 EPS (ttm)2.99 Insider Own1.80% Shs Outstand46.84M Perf Week0.85%
Market Cap3.95B Forward P/E16.64 EPS next Y5.06 Insider Trans-18.10% Shs Float46.53M Perf Month-4.73%
Income142.60M PEG2.25 EPS next Q1.13 Inst Own99.50% Short Float3.67% Perf Quarter-2.59%
Sales1.49B P/S2.64 EPS this Y16.80% Inst Trans-1.25% Short Ratio5.00 Perf Half Y12.05%
Book/sh17.67 P/B4.77 EPS next Y13.49% ROA6.30% Target Price89.89 Perf Year22.31%
Cash/sh3.83 P/C21.98 EPS next 5Y12.51% ROE18.60% 52W Range59.99 - 89.18 Perf YTD4.81%
Dividend- P/FCF16.00 EPS past 5Y21.10% ROI10.20% 52W High-5.52% Beta1.21
Dividend %- Quick Ratio1.50 Sales past 5Y3.80% Gross Margin39.50% 52W Low40.46% ATR1.42
Employees8600 Current Ratio1.70 Sales Q/Q27.80% Oper. Margin14.60% RSI (14)52.24 Volatility1.80% 1.78%
OptionableYes Debt/Eq1.64 EPS Q/Q-28.00% Profit Margin9.50% Rel Volume0.76 Prev Close84.02
ShortableYes LT Debt/Eq1.60 EarningsAug 03 BMO Payout0.00% Avg Volume341.44K Price84.26
Recom2.40 SMA200.45% SMA500.06% SMA2006.15% Volume260,541 Change0.29%
Jun-21-16Initiated Credit Suisse Neutral $84
May-20-16Reiterated Barclays Underweight $60 → $65
Apr-26-16Initiated Gabelli & Co Buy $96
Jan-07-16Upgrade Wells Fargo Market Perform → Outperform
Oct-12-15Upgrade Wells Fargo Underperform → Market Perform
Jul-31-15Reiterated Deutsche Bank Hold $76 → $79
Jul-10-15Upgrade BofA/Merrill Neutral → Buy $76 → $83
Jul-10-15Downgrade Barclays Equal Weight → Underweight $60
May-04-15Upgrade Sun Trust Rbsn Humphrey Neutral → Buy $88
Apr-24-15Reiterated Barclays Equal Weight $55 → $60
Feb-12-15Reiterated Deutsche Bank Hold $63 → $77
Feb-13-14Reiterated Barclays Equal Weight $41 → $55
Nov-21-13Initiated Deutsche Bank Hold $55
Sep-17-13Initiated UBS Neutral $49
Jun-03-13Reiterated Barclays Equal Weight $38 → $41
May-02-13Reiterated ISI Group Neutral $45.50 → $44.50
Feb-14-13Reiterated ISI Group Neutral $40.50 → $43
Jul-14-11Initiated BB&T Capital Mkts Buy $47
May-05-11Reiterated UBS Neutral $40 → $42
Jan-06-11Downgrade Deutsche Bank Buy → Hold $37 → $37
Aug-18-16 05:56PM  Moody's Upgrades Two, Affirms Three and Downgrades One Class of MLCFC 2006-2 at Moody's
Aug-11-16 10:44AM  Will This Clinical Researcher Become Next Breakout Medical Stock?
Aug-10-16 03:32PM  ETFs with exposure to Charles River Laboratories International, Inc. : August 10, 2016
01:04PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Financials
Aug-09-16 08:16AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bearish Manner : CRL-US : August 9, 2016
Aug-08-16 04:30PM  Charles River Laboratories Announces Partnership with the Milner Therapeutics Institute and Consortium Business Wire
12:07PM  Charles River Laboratories International, Inc. :CRL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 8, 2016
Aug-03-16 04:44PM  Edited Transcript of CRL earnings conference call or presentation 3-Aug-16 12:30pm GMT
08:30AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today
07:31AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
07:22AM  Charles River beats Street 2Q forecasts
07:07AM  Q2 2016 Charles River Laboratories International Inc Earnings Release - Before Market Open
07:00AM  Charles River Laboratories Announces Second-Quarter 2016 Results from Continuing Operations Business Wire
Aug-02-16 10:36AM  Healthcare Q2 Earnings Lineup for Aug 3: HUM, CRL & More
Jul-11-16 04:30PM  Charles River Laboratories Schedules Second-Quarter 2016 Earnings Release and Conference Call Business Wire
Jul-04-16 08:24AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : July 4, 2016
Jun-30-16 03:40PM  ETFs with exposure to Charles River Laboratories International, Inc. : June 30, 2016
06:50AM  Charles River CEO: 'Companies that dont grow, die' at bizjournals.com
Jun-29-16 10:34AM  5 Stocks to Buy on Stronger GDP Data
Jun-27-16 04:30PM  Charles River Laboratories Acquires Blue Stream Laboratories Business Wire -5.48%
Jun-21-16 02:22PM  Charles River Labs (CRL) Stock Falls, Credit Suisse Initiates Coverage
11:23AM  Charles River Laboratories International, Inc. Value Analysis (NYSE:CRL) : June 21, 2016
05:42AM  Coverage initiated on Charles River by Credit Suisse
Jun-20-16 08:35AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bearish Manner : CRL-US : June 20, 2016
Jun-15-16 04:21PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets
Jun-06-16 08:30AM  Charles River Laboratories to Present at Jefferies and William Blair Conferences Business Wire
08:00AM  Moderna Therapeutics and Charles River Laboratories Announce Strategic Collaboration to Scale Modernas Nonclinical Development Efforts for Novel mRNA Therapeutics Business Wire
May-16-16 09:26AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K/A, Change in Directors or Principal Officers
06:11AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in
May-12-16 03:29PM  ETFs with exposure to Charles River Laboratories International, Inc. : May 12, 2016
May-10-16 10:50AM  Charles River Laboratories International, Inc. :CRL-US: Earnings Analysis: Q1, 2016 By the Numbers
May-04-16 05:31PM  Edited Transcript of CRL earnings conference call or presentation 4-May-16 12:30pm GMT
08:30AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today
07:20AM  Charles River beats Street 1Q forecasts
07:16AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
07:07AM  Q1 2016 Charles River Laboratories International Inc Earnings Release - Before Market Open CCBN
07:00AM  Charles River Laboratories Announces First-Quarter 2016 Results from Continuing Operations Business Wire
Apr-27-16 09:30AM  The Zacks Analyst Blog Highlights: Emergent BioSolutions, Molina Healthcare, PAREXEL International, Air Methods and Charles River Laboratories International Zacks
Apr-26-16 02:32PM  Street Talk: CAT, TCS, NEM & more CNBC
11:42AM  5 Stocks to Invest on Healthcare Rebound Zacks
Apr-19-16 11:05AM  Biotech startup space Mass Innovation Labs to double Cambridge space at bizjournals.com
Apr-13-16 04:30PM  Charles River Laboratories and BioMotiv Enter into Strategic Partnership Business Wire
Apr-07-16 04:30PM  Charles River Laboratories Schedules First-Quarter 2016 Earnings Release and Conference Call Business Wire
Apr-05-16 09:18AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,
Apr-04-16 08:55AM  Charles River Laboratories Completes the Acquisition of WIL Research Business Wire
Mar-14-16 08:24AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : March 14, 2016
Mar-10-16 08:29AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-07-16 08:30AM  Charles River Laboratories to Present at Raymond James Conference Business Wire
Mar-03-16 09:40AM  Teladoc Posts Narrower-than-Estimated Q4 Loss, Offers View
08:10AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : CRL-US : March 3, 2016
Feb-29-16 05:00AM  Edited Transcript of CRL earnings conference call or presentation 7-Aug-14 1:00pm GMT
Feb-12-16 04:43PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 10-K, Annual Report
Feb-11-16 10:10AM  Charles River Laboratories International, Inc. Earnings Analysis: 2015 By the Numbers
Feb-10-16 10:32AM  Edited Transcript of CRL earnings conference call or presentation 10-Feb-16 1:30pm GMT +5.65%
08:30AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today
08:09AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
07:29AM  Charles River beats Street 4Q forecasts
07:07AM  Q4 2015 Charles River Laboratories International Inc Earnings Release - Before Market Open
07:00AM  Charles River Laboratories Announces Fourth-Quarter and Full-Year 2015 Results from Continuing Operations and Provides 2016 Guidance Business Wire
Jan-27-16 02:03PM  Charles River Laboratories International, Inc. Value Analysis (NYSE:CRL) : January 27, 2016
08:04AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : January 27, 2016
Jan-22-16 09:30AM  Zacks Investment Ideas feature highlights: AMN Healthcare Services, Charles River Lab, Healthways, INC Research and Air Methods
Jan-20-16 04:30PM  Charles River Laboratories Schedules Fourth-Quarter 2015 Earnings and 2016 Guidance Release and Conference Call Business Wire
Jan-19-16 09:30AM  New Strong Buy Stocks for January 19th
06:04AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in
Jan-13-16 08:01AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : January 13, 2016
Jan-09-16 06:00AM  Jim Cramer's Top Takeaways: Charles River Labs, Wells Fargo, Citigroup, PNC at TheStreet
Jan-08-16 04:31PM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulati
Jan-07-16 05:24PM  Charles River Laboratories Int'l, Inc. -- Moody's affirms Charles River's Ba2 CFR; outlook to stable at Moody's
06:30AM  Charles River Laboratories to Acquire WIL Research Business Wire
Dec-28-15 04:56PM  INC Research Holdings Aims For Top Five CRO Status at Investor's Business Daily
Dec-27-15 09:21PM  WEEKEND VIDEO: An Important Technical Level for the Market
01:33PM  5 Trade ideas for Monday: Agilent, BorgWarner, Charles River Labs, Intercontinental Exchange and Priogressive
Dec-14-15 07:16PM  Here is What Hedge Funds Think About Cognex Corporation (CGNX) at Insider Monkey
Dec-10-15 06:06AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Dec-08-15 08:30AM  Charles River Laboratories Expands Long-Standing Collaboration with The Michael J. Fox Foundation for Parkinsons Research Business Wire
Dec-01-15 03:24PM  Express Scripts/Imprimis to Offer Cheaper Daraprim Version
Nov-29-15 03:58AM  Here is What Hedge Funds Think About Charles River Laboratories (CRL) at Insider Monkey
Nov-26-15 04:13AM  Is Controladora Vuela Co Avcn SA CV (ADR) (VLRS) A Good Stock To Buy? at Insider Monkey
Nov-20-15 11:55AM  Why Charles River Labs spent $36M on a German drug testing business at bizjournals.com
Nov-18-15 04:15PM  Charles River Laboratories Acquires Oncotest GmbH Business Wire
10:51AM  Charles River Laboratories International, Inc. Earnings Q3, 2015
Nov-17-15 08:30AM  Regen BioPharma Inc. Submits Response to FDA Questions on HemaXellerate Investigational New Drug Application PR Newswire
Nov-16-15 01:46PM  The Best Healthcare Stock Ideas Of HealthInvest Partners AB at Insider Monkey
Nov-04-15 03:10PM  Edited Transcript of CRL earnings conference call or presentation 4-Nov-15 1:30pm GMT
08:30AM  Charles River Laboratories International Inc Earnings Call scheduled for 8:30 am ET today
08:01AM  CHARLES RIVER LABORATORIES INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Finan
07:21AM  Charles River tops Street 3Q forecasts
07:07AM  Q3 2015 Charles River Laboratories International Inc Earnings Release - Before Market Open
07:00AM  Charles River Laboratories Announces Third-Quarter 2015 Results from Continuing Operations Business Wire
Oct-29-15 02:10PM  McKesson (MCK) Beats on Earnings in Q2, Upgrades View
09:02AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : October 29, 2015
Oct-27-15 01:25PM  Charles River Laboratories International, Inc. Value Analysis (NYSE:CRL) : October 27, 2015
Oct-23-15 02:01PM  Charles River Laboratories International, Inc. Value Analysis (NYSE:CRL) : October 23, 2015
Oct-19-15 08:30AM  Charles River Laboratories Presents 25 Scientific Posters at Neuroscience 2015 Business Wire
Oct-12-15 08:42AM  Analysts' Actions -- Baidu, EMC, Exxon Mobil, NetApp and More
Oct-08-15 04:30PM  Charles River Laboratories Schedules Third-Quarter 2015 Earnings Release and Conference Call Business Wire
Oct-07-15 08:30AM  Charles River Announces New and Continued Drug Discovery Collaborations Business Wire
Sep-18-15 02:14PM  ETFs with exposure to Charles River Laboratories International, Inc. : September 18, 2015
10:53AM  Charles River Laboratories International, Inc. breached its 50 day moving average in a Bullish Manner : September 18, 2015
Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and preclinical development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening preclinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs and chickens used in the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FOSTER JAMES CChairman, President and CEOAug 05Sale86.913,830332,849323,636Aug 09 12:13 PM
FOSTER JAMES CChairman, President and CEOAug 05Sale86.308,703751,059327,466Aug 09 12:12 PM
FOSTER JAMES CChairman, President and CEOAug 05Sale85.9515,9411,370,104336,169Aug 09 12:10 PM
FOSTER JAMES CChairman, President and CEOAug 05Sale85.8013,1751,130,379352,110Aug 09 12:08 PM
FOSTER JAMES CChairman, President and CEOAug 05Sale85.6318,3511,571,433365,285Aug 09 12:06 PM
WALLMAN RICHARD FDirectorJul 29Option Exercise40.277,740311,69024,190Aug 01 04:00 PM
WALLMAN RICHARD FDirectorJul 29Sale88.007,740681,12016,450Aug 01 04:00 PM
MASSARO GEORGEDirectorJul 01Option Exercise33.934,540154,04218,935Jul 05 01:17 PM
MASSARO GEORGEDirectorJul 01Sale83.5480066,83114,395Jul 05 01:19 PM
MASSARO GEORGEDirectorJul 01Sale83.093,740310,75015,195Jul 05 01:17 PM
WALLMAN RICHARD FDirectorMay 13Sale82.321,970162,18016,450May 16 03:01 PM
MASSARO GEORGEDirectorMay 09Sale82.1798580,94212,135May 10 01:15 PM
Molho DavideCorporate Executive VPApr 06Option Exercise37.9630,6671,164,04490,012Apr 08 07:05 AM
Molho DavideCorporate Executive VPApr 06Sale80.0030,6672,453,36059,345Apr 08 07:05 AM
GILLETT NANCYCorporate Executive VPMar 02Option Exercise44.3115,419683,19033,726Mar 04 12:05 PM
FOSTER JAMES CChairman, President and CEOMar 02Option Exercise59.4120,0721,192,478403,708Mar 04 06:40 PM
FOSTER JAMES CChairman, President and CEOMar 02Sale75.0020,0721,505,400383,636Mar 04 06:40 PM
GILLETT NANCYCorporate Executive VPMar 02Sale75.219,775735,21316,936Mar 04 12:07 PM
GILLETT NANCYCorporate Executive VPMar 02Sale75.007,015526,12526,711Mar 04 12:05 PM
GILLETT NANCYCorporate Executive VPMar 02Sale75.8282262,32811,034Mar 04 12:12 PM
GILLETT NANCYCorporate Executive VPMar 02Sale75.505,080383,55311,856Mar 04 12:09 PM
GILLETT NANCYCorporate Executive VPFeb 29Sale73.503,646267,98118,307Feb 29 05:43 PM
JOHST DAVID PCorporate Executive VPFeb 25Option Exercise24.8034,075845,060189,023Feb 29 05:47 PM
JOHST DAVID PCorporate Executive VPFeb 25Sale73.0234,0752,488,146154,948Feb 29 05:47 PM
FOSTER JAMES CChairman, President and CEOFeb 24Option Exercise36.2524,388884,065402,707Feb 26 12:17 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale72.8980058,309378,319Feb 26 12:32 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale72.104,162300,073382,672Feb 26 12:29 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale72.543,553257,741379,119Feb 26 12:30 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale71.324,500320,919390,834Feb 26 12:25 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale71.774,000287,097386,834Feb 26 12:27 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale70.793,500247,768395,334Feb 26 12:20 PM
FOSTER JAMES CChairman, President and CEOFeb 24Sale70.403,873272,644398,834Feb 26 12:17 PM
MILNE GEORGE M JRDirectorFeb 23Option Exercise28.2910,440295,34838,200Feb 24 02:55 PM
CHUBB STEPHEN DDirectorFeb 23Option Exercise28.2910,440295,34821,944Feb 24 07:38 PM
CHUBB STEPHEN DDirectorFeb 23Sale72.874,065296,21617,879Feb 24 07:38 PM
MILNE GEORGE M JRDirectorFeb 23Sale73.0210,440762,31927,760Feb 24 02:55 PM
FOSTER JAMES CChairman, President and CEOFeb 22Option Exercise40.4021,779879,872402,964Feb 23 11:46 AM
FOSTER JAMES CChairman, President and CEOFeb 22Sale74.092,738202,847381,185Feb 23 11:51 AM
FOSTER JAMES CChairman, President and CEOFeb 22Sale73.379,210675,740383,923Feb 23 11:49 AM
FOSTER JAMES CChairman, President and CEOFeb 22Sale73.129,831718,830393,133Feb 23 11:46 AM
ACKERMAN THOMAS FSenior Financial AdvisorFeb 16Option Exercise39.2513,211518,559124,909Feb 19 07:27 AM
ACKERMAN THOMAS FSenior Financial AdvisorFeb 16Sale74.372,200163,605111,698Feb 19 07:31 AM
ACKERMAN THOMAS FSenior Financial AdvisorFeb 16Sale73.896,152454,568113,898Feb 19 07:30 AM
ACKERMAN THOMAS FSenior Financial AdvisorFeb 16Sale73.414,859356,713120,050Feb 19 07:27 AM
REESE C RICHARDDirectorFeb 12Option Exercise28.3910,440296,39235,351Feb 17 12:19 PM
GILLETT NANCYCorporate Executive VPFeb 12Sale71.906,750485,32525,392Feb 17 12:21 PM
REESE C RICHARDDirectorFeb 12Sale71.484,228302,23831,123Feb 17 12:19 PM
CHUBB STEPHEN DDirectorFeb 01Sale74.762,000149,52311,504Feb 03 09:38 AM
MASSARO GEORGEDirectorDec 17Option Exercise40.277,740311,69020,860Dec 18 02:08 PM
ACKERMAN THOMAS FSenior Financial AdvisorDec 17Option Exercise37.0310,000370,300110,635Dec 18 01:57 PM
MASSARO GEORGEDirectorDec 17Sale80.007,740619,20013,120Dec 18 02:08 PM
ACKERMAN THOMAS FSenior Financial AdvisorDec 17Sale80.0010,000800,000100,635Dec 18 01:57 PM
ACKERMAN THOMAS FSenior Financial AdvisorNov 19Option Exercise37.0310,000370,300110,635Nov 20 12:57 PM
ACKERMAN THOMAS FSenior Financial AdvisorNov 19Sale75.0010,000750,000100,635Nov 20 12:57 PM
ACKERMAN THOMAS FSenior Financial AdvisorNov 04Option Exercise36.7921,612795,135122,247Nov 06 10:04 AM
ACKERMAN THOMAS FSenior Financial AdvisorNov 04Sale70.0121,6121,512,971100,635Nov 06 10:04 AM